J. Goldman & Co LP - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 19 filers reported holding VINCERX PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q1 2022$172,000
-60.8%
43,1010.0%0.01%
-66.7%
Q4 2021$439,000
-70.9%
43,101
-62.9%
0.02%
-59.3%
Q2 2021$1,509,000
+65.6%
116,160
-4.0%
0.06%
+96.7%
Q1 2021$911,000
-35.6%
120,955
-17.0%
0.03%
-58.3%
Q4 2020$1,414,000145,6420.07%
Other shareholders
VINCERX PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,703,413$1,720,4470.48%
Tejara Capital Ltd 233,348$235,6810.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$388,8500.04%
SABBY MANAGEMENT, LLC 57,353$57,9270.04%
Long Focus Capital Management, LLC 1,098,753$1,109,7410.04%
Sio Capital Management, LLC 102,049$103,0690.03%
Rock Springs Capital Management LP 891,719$900,6360.02%
Rubric Capital Management LP 354,377$357,9210.01%
Clearline Capital LP 98,916$99,9050.01%
ExodusPoint Capital Management, LP 389,512$3930.00%
View complete list of VINCERX PHARMA INC shareholders